The product, Xenpozyme is an enzyme replacement therapy for acid sphingomyelinase deficiency which causes an accumulation of a fat in important organs, resulting in premature death.
The director-general of health, Dr Radzi Abu Hassan, said the product had been given priority to enable patients to gain immediate access.
The director-general of health, Dr Radzi Abu Hassan, said approval was granted at a meeting of the Drug Control Authority on Thursday.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
MOH approves Xenpozyme to treat ASMD - Health DGKUALA LUMPUR: The Ministry of Health (MOH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sph...
Leggi di più »
KKM lulus ubat rawat penyakit jarang jumpaProduk Xenpozyme dikilangkan oleh Genzyme Ireland Limited, Ireland dengan Sanofi-Aventis (Malaysia) Sdn. Bhd. sebagai pemegang pendaftaran produk.
Leggi di più »
PM Anwar: Govt identifying locations for foreign investors in the renewable energy sectorABU DHABI, Oct 7 ― The government will identify several suitable locations for foreign investors interested in the renewable energy sector, Prime Minister Datuk Seri Anwar...
Leggi di più »
Fahmi: Govt to look into Indonesia's move to ban e-commerce sales on TikTokKUALA LUMPUR: The government will look into the action taken by the Indonesian government to ban e-commerce transactions on the social media platform ...
Leggi di più »
Govt studying Indonesia’s move to ban e-commerce sales on TikTokCommunications and digital minister Fahmi Fadzil says several large stores had raised issues related to price competition for products sold through the platform.
Leggi di più »